Aspen Pharmacare Ltd. Is Behind US$585 Million Sigma Pharmaceuticals Bid; Advisors Hope to Solicitate a Superior Offer

May 24, 2010 |

1 min read

WSJ -- Sigma Pharmaceuticals Ltd. on Monday confirmed that South Africa's Aspen Pharmacare Holdings Ltd. was behind last week's 707 million Australian dollar (US$585 million) bid for the group.

Mergers & acquisitions

MORE ON THIS TOPIC

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie

Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.

Funding

Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug

March 4, 2026

·

2 min read

·

Tristan Manalac

Reaching an agreement. Businessmen shake hands and make a deal. vector

Immunology and inflammation

Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals

March 4, 2026

·

2 min read

·

Tristan Manalac